BRIEF-Vertex enrollment complete in Phase 3 study in people with two copies of F508DE
 

BRIEF-Vertex enrollment complete in Phase 3 study in people with two copies of F508DEL mutation
* Provides update on ongoing phase 3 program For VX-661 incombination with ivacaftor for the treatment of cystic fibrosishttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...SU:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...SU:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/iabcPQ-5Ze4